Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 6,294 INR
Change Today +26.60 / 0.42%
Volume 33.4K
SKB On Other Exchanges
Natl India
As of 7:06 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

glaxosmithkline consumer hea (SKB) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/15/15 - 6,575
52 Week Low
08/7/14 - 4,701
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

glaxosmithkline consumer hea (SKB) Related Businessweek News

No Related Businessweek News Found

glaxosmithkline consumer hea (SKB) Details

GlaxoSmithKline Consumer Healthcare Limited operates in the health food drinks industry in India. The company manufactures and markets nutritional supplements, biscuits, and malt-based and chocolate health food drinks under the Horlicks, Boost, Maltova, and Viva brand names. It also offers over-the-counter medicine, including Crocin, a pain and body ache relieving drug; Crocin Pain Relief, a pain relief medicine; Crocin Cold and Flu, which provides relief from cold; and Crocin paediatric medicines for infants, toddlers, and older kids up to 12 years. In addition, the company provides Eno, an antacid for acidity, gastric discomfort, and heat burn; and Iodex for head, neck, back joint, and muscular pains, as well as Iodex creams and gels; and oral care products under the Sensodyne brand name. Further, it offers its products under the Voltaren, Theraflu, Paradontax, Panadol, Polident, Otrivin, and Physiogel brands. The company exports its products to Bangladesh, Sri Lanka, Bhutan, the Middle East, Myanmar, and Pakistan. GlaxoSmithKline Consumer Healthcare Limited was incorporated in 1958 and is headquartered in Gurgaon, India.

3,527 Employees
Last Reported Date: 07/10/15
Founded in 1958

glaxosmithkline consumer hea (SKB) Top Compensated Officers

Director of Operations, Wholetime Director an...
Total Annual Compensation: 18.1M
Compliance Officer, General Manager of Legal ...
Total Annual Compensation: 5.2M
Compensation as of Fiscal Year 2015.

glaxosmithkline consumer hea (SKB) Key Developments

GlaxoSmithKline Consumer Healthcare Announces Lay Off 350 Employees from its Two Facilities in Parsippany by the End of 2015

GlaxoSmithKline Consumer Healthcare has announced it'll lay off 350 employees from its two facilities in Parsippany by the end of 2015. The company later filed a notice with state Department of Labor and Workforce Development announcing the layoffs.

GlaxoSmithKline Consumer Healthcare Limited Announces Management Changes

GlaxoSmithkline Consumer Healthcare Ltd. announced that Mr. Manoj Kumar has been appointed as the Managing Director of the Company in place of Mr. Zubair Ahmed with effect from June 1, 2015 under the provisions of Article 97 A of the Articles of Association of the Company and approved by the Board of Directors at its meeting held on May 08, 2015. Further inform that the Board noted the withdrawal of nomination by Horlicks Limited of Mr. Zubair Ahmed as the Director of the Company with effect from the close of business hours on May 31, 2015 and accepted his resignation. The Board had also appointed Mr. Vivek Anand as a Whoietime Director and Chief Financial Officer of the Company, with effect from June 01, 2015, in the casual vacancy caused by the resignation of Mr. Ramakrishnan Subramanian, Director - Finance. Mr. Ahmed and Mr. Subramanian have been appointed to the leadership team of Asia Pacific, Middle East and Africa operations of GSK Consumer Healthcare, as Head of the region and Vice President Finance respectively. While in their new roles, Mr. Kumar will report into Mr. Ahmed and Mr. Anand will be reporting in to Mr. Subramanian. Mr. Ahmed and Mr. Subramanian will continue to guide them on matters pertaining to the listed entity.

Glaxosmithkline Consumer Healthcare Limited Recommends Dividend, Payable on or Before September 05, 2015

GlaxoSmithKline Consumer Healthcare Limited announced that the Board of Directors of the company at its meeting held on May 08, 2015, has recommended a Dividend at the rate of INR 55 per equity share of INR 10 each. The dividend shall be paid to the entitled Members on or before September 05, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SKB:IN 6,294.25 INR +26.60

SKB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arena Pharmaceuticals Inc $3.97 USD -0.12
DC Brands International Inc $0.0001 USD 0.00
Perrigo Co PLC $191.43 USD -1.40
VIVUS Inc $1.73 USD 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation SKB Industry Range
Price/Earnings 44.2x
Price/Sales 6.0x
Price/Book 12.2x
Price/Cash Flow 40.0x
TEV/Sales 5.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE CONSUMER HEA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at